Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers
出版年份 2016 全文链接
标题
Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers
作者
关键词
-
出版物
Translational Psychiatry
Volume 6, Issue 1, Pages e713-e713
出版商
Springer Nature
发表日期
2016-01-20
DOI
10.1038/tp.2015.209
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in c57bl/6j mice.
- (2014) Rachel L. Poole et al. BEHAVIORAL NEUROSCIENCE
- Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats
- (2014) Alycia M. Lee et al. BEHAVIOURAL BRAIN RESEARCH
- Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal
- (2014) Rebecca L Ashare et al. Expert Opinion on Drug Discovery
- Pharmacological Treatments for Smoking Cessation
- (2014) Kate Cahill et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Working Memory-Related Neural Activity Predicts Future Smoking Relapse
- (2014) James Loughead et al. NEUROPSYCHOPHARMACOLOGY
- Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications
- (2013) Kenneth A. Perkins et al. ADDICTION
- Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach
- (2013) Bernard Le Foll et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration
- (2013) Xiu Liu PSYCHOPHARMACOLOGY
- Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats
- (2013) Eric G. Mohler et al. PSYCHOPHARMACOLOGY
- Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats
- (2012) Blake A. Kimmey et al. ADDICTION BIOLOGY
- Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: A pilot feasibility study
- (2012) Rebecca L. Ashare et al. DRUG AND ALCOHOL DEPENDENCE
- Cognitive enhancement as a treatment for drug addictions
- (2012) Mehmet Sofuoglu et al. NEUROPHARMACOLOGY
- Galantamine, an Acetylcholinesterase Inhibitor and Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors, Attenuates Nicotine Taking and Seeking in Rats
- (2012) Thomas J Hopkins et al. NEUROPSYCHOPHARMACOLOGY
- Smoking-Attributable Mortality by Cause in the United States: Revising the CDC's Data and Estimates
- (2012) B. Rostron NICOTINE & TOBACCO RESEARCH
- Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report
- (2012) Mehmet Sofuoglu et al. PSYCHOPHARMACOLOGY
- Reward, Addiction, Withdrawal to Nicotine
- (2011) Mariella De Biasi et al. Annual Review of Neuroscience
- Use of Varenicline for 4 Weeks Before Quitting Smoking
- (2011) Peter Hajek et al. ARCHIVES OF INTERNAL MEDICINE
- The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice
- (2011) Derek S. Wilkinson et al. BEHAVIOURAL BRAIN RESEARCH
- Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior
- (2011) Luis M. Tuesta et al. BIOCHEMICAL PHARMACOLOGY
- Lorcaserin, a 5-HT2C Agonist, Decreases Nicotine Self-Administration in Female Rats
- (2011) E. D. Levin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Assessing Recent Smoking Status by Measuring Exhaled Carbon Monoxide Levels
- (2011) AnnSofi Sandberg et al. PLoS One
- Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers
- (2011) R. De La Garza et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Impact of self-initiated pre-quit smoking reduction on cessation rates: Results of a clinical trial of smoking cessation among female prisoners
- (2010) Karen L. Cropsey et al. ADDICTIVE BEHAVIORS
- Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats
- (2010) Alessandra Giarola et al. BEHAVIOURAL PHARMACOLOGY
- Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans
- (2010) K A Perkins et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
- (2010) Martin R. Farlow et al. CLINICAL THERAPEUTICS
- Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats
- (2010) C. W. Goh et al. DRUG METABOLISM AND DISPOSITION
- Histamine H1 antagonist treatment with pyrilamine reduces nicotine self-administration in rats
- (2010) Edward D. Levin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
- (2010) M. Giorgetti et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration
- (2010) Olivier George et al. PSYCHOPHARMACOLOGY
- Working memory deficits predict short-term smoking resumption following brief abstinence
- (2009) Freda Patterson et al. DRUG AND ALCOHOL DEPENDENCE
- Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimerʼs Disease
- (2009) Stephen Aronson et al. DRUGS & AGING
- Rivastigmine Reduces Tobacco Craving in Alcohol-dependent Smokers
- (2009) A. Diehl et al. PHARMACOPSYCHIATRY
- The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
- (2009) Eoin C. O’Connor et al. PSYCHOPHARMACOLOGY
- Lack of beneficial galantamine effect for smoking behavior: A double-blind randomized trial in people with schizophrenia
- (2008) Deanna L. Kelly et al. SCHIZOPHRENIA RESEARCH
- One-week dose titration of extended release galantamine in patients with Alzheimer’s disease
- (2007) Douglas W. Scharre et al. Alzheimers & Dementia
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started